July 24, 2015 | The U.S. Food and Drug
Administration has approved the Bio-Rad BioPlex 2200 HIV Ag-Ab
assay, the first FDA-approved diagnostic that differentiates
between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen
in human serum or plasma specimens. FDA News